CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,804 | -15.8% | 1,011,627 | -6.8% | 0.00% | -20.0% |
| Q2 2023 | $35,403 | -14.2% | 1,085,313 | -7.4% | 0.01% | -16.7% |
| Q1 2023 | $41,245 | -18.7% | 1,172,029 | +5.8% | 0.01% | -25.0% |
| Q4 2022 | $50,762 | -99.9% | 1,107,861 | +1.3% | 0.01% | -11.1% |
| Q3 2022 | $52,978,000 | +170.9% | 1,093,447 | +119.7% | 0.01% | +350.0% |
| Q2 2022 | $19,556,000 | +14.9% | 497,739 | +7.6% | 0.00% | 0.0% |
| Q1 2022 | $17,024,000 | +149.9% | 462,483 | +209.5% | 0.00% | +100.0% |
| Q4 2021 | $6,811,000 | +546.8% | 149,439 | +407.3% | 0.00% | – |
| Q3 2021 | $1,053,000 | +87.0% | 29,457 | +3.6% | 0.00% | – |
| Q2 2021 | $563,000 | -10.9% | 28,441 | +4.6% | 0.00% | – |
| Q1 2021 | $632,000 | +29.2% | 27,180 | +15.5% | 0.00% | – |
| Q4 2020 | $489,000 | -96.6% | 23,526 | -96.4% | 0.00% | -100.0% |
| Q3 2020 | $14,292,000 | +310.6% | 660,154 | +54.5% | 0.00% | +100.0% |
| Q4 2017 | $3,481,000 | -43.5% | 427,148 | +0.4% | 0.00% | 0.0% |
| Q3 2017 | $6,166,000 | -43.3% | 425,258 | -70.3% | 0.00% | -66.7% |
| Q3 2013 | $10,866,000 | -68.1% | 1,431,573 | -51.4% | 0.00% | -40.0% |
| Q2 2013 | $34,106,000 | – | 2,947,716 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |